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ABBREVIATIONS 
 
AKI - Acute kidney injury; Lesão renal aguda 
ANA- Anti-nuclear antibodies 
ANCA - Anti-neutrophil cytoplasmic antibody 
CAIE  - Community-acquired infective endocarditis; Endocardite infecciosa adquirida  na 
comunidade 
CKD - Chronic kidney disease; Insuficiência renal crónica  
ICD - Implantable cardioverter defibrillator; Cardioversor desfibrilhador implantável 
IE - Infective endocarditis; Endocardite infecciosa 
IQR - Interquartile range; Amplitude interquartil 
IVDA - Intra-venous drug abuse; Abuso de substâncias por via endovenosa 
HAIE - Health-care associated infective endocarditis; Endocardite infecciosa associada aos 
cuidados de saúde 
HF - Heart failure; Insuficiência cardíaca 
MRSA - Methicillin-resistant Staphylococcus aureus 
PVE - Prosthetic valve endocarditis; Endocardite de válvula prostética 
TTE - Transthoracical echocardiography; Ecocardiograma transtorácico 
TEE - Transoesophageal echocardiography; Ecocardiograma transesofágico 
VRE - Vancomycin-resistant Enterococci spp. 
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ABSTRACT 
 
Aims: The aim of this study is to provide an epidemiological profile of infective endocarditis 
(IE),  to determine temporal trends through a direct comparison with a previous cohort and to 
assess factors that impact in-hospital mortality. 
Methods and results: A total of 25 patients prospectively identified with clinical diagnosis of 
IE and definite or possible diagnosis according to modified Duke criteria were included in the 
study. Fifty-two percent of the episodes involved prosthetic valves and 17% were health-care 
associated (HAIE). Causative microorganisms were 32% Staphylococci spp., 32% 
Streptococci spp.  and 12 % Enterococci spp. S.aureus was the main isolated causative 
microorganism (24%). At least one complication occurred in 72% of the episodes and 84% 
had at least one surgical indication. Fifty-two percent of the patients were submitted to 
surgical treatment after a median 30 days after  admission (IQR=11-40)  in comparison to 
29% after a median 38 days  (IQR=29-59) in the previous cohort. In-hospital all-cause 
mortality was 28% comparing with 36% in the previous  cohort.  Six-month mortality was 
30% (2 patients were lost to follow-up) comparing to 47% in the previous series. Seventy-five 
percent of the patients with surgical indication and not submitted to surgical treatment died in-
hospital. In univariate analysis multidrug-resistant microorganisms (100% vs 28% p=0,042), 
health-care acquisition (75% vs 20% p=0,027), community acquisition (16% vs 80% p =0,005) 
and surgery (0% vs. 58% p=0,001) influenced in-hospital mortality.  
Conclusion: We could observe a higher proportion of patients with prosthetic valves and 
other comorbidities. S.aureus was the main isolate cause of IE  but Staphylococci spp. and 
Streptococci spp. cases were even. IE continues to present with high in-hospital and 6-month 
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mortality-rates though lower than in the last decade.  The proportion of surgically treated 
patients has increased and surgery was associated with  lower in-hospital mortality. 
Keywords: Infective endocarditis; epidemiology; prognostic factors; in-hospital mortality; 6-
month  mortality. 
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RESUMO 
 
Objectivos: O objectivo deste estudo é traçar um perfil epidemiológico de Endocardite 
Infecciosa (EI), analisar a sua evolução em comparação directa com uma coorte  anterior e 
determinar factores com impacto na mortalidade intra-hospitalar. 
Métodos e resultados: Foram incluídos neste estudo 25 doentes  prospectivamente 
identificados com diagnóstico clínico de  EI e diagnóstico definitivo ou possível de acordo 
com os critérios de Duke modificados.  Cinquenta e dois porcento dos episódios foram em 
doentes com válvulas prostéticas e 17% tiveram aquisição associada aos cuidados de saúde 
(HAIE). Os microorganismos causadores incluiram 32% Staphylococci spp., 32% 
Streptococci spp. e 12% Enterococci spp. O principal agente causador de IE isoladamente foi 
o S.aureus (24%). Pelo menos uma complicação clínica ocorreu em 72% dos episódios e 84% 
tinham pelo menos uma indicação cirúrgica. Foram submetidos a intervenção cirúrgica 52% 
dos doentes após uma mediana de 30 dias (IQR=11-40) depois da admissão em comparação 
com 29% após mediana de 38  dias (IQR=29-59)  na coorte anterior. A mortalidade intra-
hospitalar foi de 28% em comparação com 36% na coorte anterior. A mortalidade a 6 meses 
foi de 30% (perderam-se dois doentes no follow-up) em comparação com 47% na série 
anterior. Nos doentes com indicação cirúrgica que não foram submetidos a cirurgia a 
mortalidade intra-hospitalar foi de 75%.  Na análise univariada microorganismos multi-
resistentes (100% vs 28% p=0,042), a aquisição associada aos  cuidados de saúde (75% vs 20% 
p=0,027), a  aquisição comunitária (16% vs 80% p =0,005) e a cirurgia (0% vs. 58% p=0,001) 
tiveram impacto na mortalidade intra-hospitalar.  
Conclusão: Pudemos observar um aumento dos doentes com válvulas prostéticas e outras 
comorbilidades. Isoladamente o principal microorganismo causador foi o S.aureus mas a 
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frequência de Staphylococci spp. e Streptococci spp. foi igual. A EI continua a estar  
associada a elevadas taxas de mortalidade intra-hospitalar e a 6 meses apesar de ter havido 
uma diminuição das mesmas em relação à década passada. A  proporção de doentes tratados 
cirurgicamente aumentou e a cirugia teve impacto positivo na mortalidade intra-hospitalar. 
 
Palavras-chave: Endocardite infecciosa; epidemiologia; factores prognósticos; mortalidade 
intra-hospitalar; mortalidade a 6 meses. 
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INTRODUCTION 
 
The epidemiological profile of infective endocarditis (IE) has changed substantially, 
particularly in developed nations, since its first modern clinical description by Osler in 1885 
a
 
(1).  
Nowadays the classic manifestations and predisposing conditions are unusual; instead IE 
tends to present in an older population, with more comorbidities and with increasing presence 
of intracardiac devices or prosthetic valves (2–4). Also, the exposure to invasive healthcare 
procedures has been increasingly related with IE incidence (5,6). Regarding microbiology, it 
has been registered a trend that shows Staphylocoocus aureus as the predominant IE agent 
surpassing Streptococcus viridans (3,5–8). Despite being a rare disease, 3-10 episodes/100 
000 person-years (2), and the fact that major advances have been made in both diagnostic and 
therapeutic procedures, it is still associated with poor prognosis, with in-hospital mortality 
ranging from 16,6% - 22,7% (5,8,9), 6-month mortality ranging from 18% to22% (3,10) and 
long-term mortality ranging from 56% to 69% (11,12). 
In addition, IE is a very heterogeneous disease, presenting with several different 
manifestations, depending, among other factors, on the underlying health status, predisposing 
conditions of the patient and its causative microorganisms. Regarding treatment, it has been 
reported a protective effect of surgical treatment (5,11) in the course of IE but there is still no 
absolute consensus about indications, contra-indications and timing, particularly on critically 
ill patients (3,12–14). Moreover, geographical differences have been reported in IE (5) and for 
that reason a contemporary epidemiological study of this disease in Portugal seemed 
opportune. Additionally, it is important to assess the temporal trends regarding surgical 
approaches and intra-hospital mortality. 
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The aim of this study was 1) to assess factors that impact in-hospital mortality and 2) to 
provide an epidemiological profile of IE. We also aimed to determine temporal trends through 
a direct comparison with a previous cohort of IE patients. 
 
METHODS 
 
A total of 25 patients that were discharged from Hospital of University of Coimbra - Portugal 
between June 2013 and June 2014 were included in the study if prospectively identified with 
clinical and definite or possible diagnosis of IE according to modified Duke criteria (15). 
Data collection 
For each patient the following variables were collected:  
 Epidemiological: age, sex, predisposing conditions for IE, cardiovascular risk factors, 
other comorbidities (pulmonary, hepatic, renal, immunosuppression), hemodialysis, 
presence of chronic intravenous catheter or arteriovenous fistula. 
 Microbiological: blood cultures, serology and antimicrobial susceptibility testing. 
 Diagnostic tools: transthoracic echocardiography (TTE), transesophageal 
echocardiography (TEE), location and size of the vegetations, valvular regurgitation or 
stenosis, qualitative systolic function, paravalvular complications and time till TTE/TEE. 
 Clinical presentation: constitutional symptoms, new regurgitation, heart murmur, 
vascular signs, neurological signs, confusion, anemia, chest pain, arthralgia respiratory 
symptoms, gastro-intestinal symptoms. 
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 Complications: Heart failure (HF), cerebral embolism, other embolic phenomena, acute 
pulmonary edema, acute kidney injury (AKI). 
 Surgical treatment: type of surgery performed, type of implanted valve, time till surgery. 
Indications for surgery were 1) severe aortic or mitral regurgitation causing acute 
pulmonary edema or shock; 2) Severe aortic or mitral regurgitation and persisting heart 
failure; 3) Abscess, pseudoaneurysm or fistula; 4) Persisting fever and positive blood 
cultures for more than 10 days; 5) infection caused by multi-resistant microorganisms; 6) 
Vegetations with more than 10mm and predictors of complicated course (HF; 
uncontrolled infection); 7) Vegetations with more than 15mm.   
 Outcomes: length of stay in hospital, in-hospital mortality rate, 6-month mortality rate, 
reinfection and need for another surgery.   
 
Definitions 
Acute kidney injury: Defined as an increase in serum creatinine > to 1.5 times baseline 
during in-hospital stay and considering the baseline as the value at admission (16).  
Anemia: hemoglobin concentration < 12.0 g/dL for females and < 13.0g/dL for males. 
Autoimmunity: ANA+ and/or ANCA+ and/or Anti ds-DNA+ and/or rheumatoid factor.  
The following definitions were made according to the 2009 European Society of Cardiology 
Infective Endocarditis guidelines: community acquired IE, health-care associated IE (HAIE), 
early prosthetic valve endocarditis (PVE), late PVE, recurrence and relapse.  
Imunosupression: Human immunodeficiency virus infection, malignancy, and/or long-term 
use of corticosteroids and/or other immunosuppressant (12). 
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Time till cardiac surgery: Time in days from TTE/TEE until the day of the surgery. If the 
patient has done both, counting from TEE day given its higher sensitivity and specificity to IE 
diagnose (17) and assuming that, TTE, if done first, was not conclusive. 
Time till TTE/TEE: Time in days from admission to TTE/TEE whichever was done first. In 
case of transferred patients sometimes it presents has a negative value given that it was 
performed before admission in the hospital in study; these were not included for median 
calculation of time till TTE/TEE. 
MRSA: methicillin-resistant Staphylococcus aureus 
Multiresistant microorganism: Defined as Methicilin Resistant Staphylococcus aureus 
(MRSA), vancomycin-resistant Enterococci spp. (VRE) and penicilin-resistant Enterococci 
spp.  and penicilin-resistant Streptococci spp.  
New regurgitation: According to the following criteria 1) Patient with regurgitation and 
without previous heart valve disease 2) Patient with previous heart valve disease but 
presenting with severe regurgitation in a native heart valve 3) Patient with previous heart 
valve disease but  presenting with mild regurgitation and vegetation in a native heart valve. 
Periannular complications: Paravalvular leak, fistula, abscess, pseudoaneurysm. 
Predisposing condition for IE: If a patient fills at least one of the following criteria 1)  
previous heart valve disease; 2) congenital heart disease; 3) previous infective endocarditis; 4) 
acute rheumatic fever; 5) prosthetic valve; 6) intracardiac device; 7) intravenous drug abuse 
(IVDA). 
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Statistical analysis 
Continuous data were presented as medians and interquartile ranges (IQR), unless stated 
otherwise, and categorical data as the frequency. We used Kolmogorov-Smirnov for testing 
normality, Student’s T-test for continuous variables and Χ2-test for categorical variables. 
Values of p < 0.05 were considered to be significant. Due to low numbers and consequently, 
low power, we have refrained from hypothesis testing comparing the contemporary and the 
older IE cohorts. Results are presented numerically. Statistical analysis was performed using 
SPSS® 17.0 software package (IBM, New York, USA). 
 
RESULTS 
 
The median age of the cohort was 59 years (IQR = 50-75) and 72% were male. In the 24 cases 
in which was possible to determine acquisition, 79% (n=17) were community-acquired, 17% 
(n=4) were health-care associated, 1 was nosocomial and in 1 patient IE was associated with 
IVDA. Almost half of the patients were referred from another health-care facility (n = 12), as 
our hospital is a tertiary centre. 
 
Clinical presentation 
 
The distribution of underlying heart disease, cardiovascular risk factors and other 
comorbidities is shown in Table 1. In 76% of the patients was identified at least one 
predisposing condition for IE. The most common underlying heart conditions were 
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degenerative heart valve disease (52%) and a history of cardiothoracic surgery (52%), mainly 
aortic valve replacement (62%), resulting in a high proportion of patients with PVE (40%). 
Among these patients in 90% of the cases it occurred more than 1 year after valve surgery and 
in equal proportion were related to mechanic or biological valves. 
Clinical findings are summarized in Table 2. The most common manifestations of the disease 
were fever (80%), anemia (76%), mainly normochromic normocytic (89%), presence of a 
heart murmur (72%) and a new regurgitation (72%).  
Table  1. IE type, risk factors, comorbidities and predisposing conditions 
    Variable n Total n % 
Demographic Data    
Age (IQR = 50-75) 59  
Male gender 18 25 72% 
    IE type    
    Native valve  15 25 60% 
Prosthetic valve 10 25 40% 
Early PVE 1 10 10% 
Late PVE 9 10 90% 
Mechanical Valve IE 5 10 50% 
Biological Valve IE 5 10 50% 
    Cardiovascular risk factors    
    Arterial hypertension 16 25 64% 
Dyslipidemia 12 25 48% 
Diabetes 8 25 32% 
    Comorbilities    
    Degenerative heart valve disease 13 25 52% 
Coronary disease 8 25 32% 
Acute myocardial infarction 4 25 16% 
Congestive heart failure 9 25 36% 
Stroke 2 25 8% 
Atrial Fibrillation  8 25 32% 
Previous endocarditis 5 25 20% 
Relapse 1 5 20% 
Recurrence 4 5 80% 
Congenital heart disease 5 25 20% 
Bicuspid aortic valve 4 5 80% 
Aortic coarctacion and interventricular communication 1 5 20% 
Pacemaker or ICD 5 25 20% 
Previous cardiothoracic surgery 13 25 52% 
Mitral valve repair 1 13 8% 
Aortic valve repair 1 13 8% 
Aortic valve replacement 8 13 62% 
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Mitral valve repair and aortic valve replacement   1 13 8% 
Mitral and aortic valves replacement 1 13 8% 
Aortic coarctacion correction 1 13 8% 
Rheumatical heart disease  2 25 8% 
Lung disease † 5 25 20% 
Cronic kidney failure 3 25 12% 
Hemodialysis 0 25 0% 
Chronic iv catheter 0 25 0% 
Chronic liver disease 0 25 0% 
Hepatitis 1 25 4% 
Imunosupression  2 25 8% 
IVDA 1 25 4% 
Auto-immunity  7 25 28% 
Rheumatoid factor 0 7 0% 
Antinuclear antibodies (ANA) 5 7 71% 
 Anti-neutrophil cytoplasmic antibody (ANCA) 1 7 14% 
Anti  ds-DNA 1 7 14% 
    Minor  Duke criteria  - Predisposition 19 25 76% 
Minor  Duke criteria  - Immunological phenomena 1 25 4% 
        † : including obstructive lung disease and pulmonary fibrosis  
 
Table 2. Clinical Presentation 
    Variable n Total n % 
Asthenia 11 25 44% 
Anorexia 5 25 20% 
Arthralgia 2 25 8% 
Chest pain 6 25 24% 
Nausea 3 25 12% 
Vomit 1 25 4% 
Cough 4 25 16% 
Productive cough 2 25 8% 
Dyspnoea 7 25 28% 
Orthopnea 2 25 8% 
Peripheral edema 9 25 36% 
Acute pulmonary edema 3 25 12% 
Fever 20 25 80% 
Anemia 19 25 76% 
Normocytic normochromic 17 19 89% 
Microcytic 1 19 5% 
Macrocytic 1 19 5% 
Confusion 6 25 24% 
Neurological Signs 6 25 24% 
Vascular Signs 4 25 16% 
Peripheral abscess 0 25 0% 
Heart murmur 18 25 72% 
New regurgitation 18 25 72% 
        
Minor  Duke criteria - fever 20 25 80% 
Minor  Duke criteria - vascular phenomena † 6 25 24% 
    † including not only vascular signs  at admission but also complications 
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Microbiology 
 
Blood cultures were taken from all 25 patients to determine the causative microorganism. Of 
the 5 patients with negative blood cultures, the majority (3 patients) had received antibiotics 
before the blood samplings. The distribution of causative microorganisms and their 
resistances is displayed in Table 3. Streptococci spp. (32%) and Staphylococci spp. (32%) 
were equally common; Enterococci spp. were responsible for a minority of cases (12%). 
Inside the Staphylococci spp. the most frequent microorganism was S. aureus accounting for 
24% of IE cases. Of these, 33% were due to MRSA. In 85% of all positive blood cultures 
antimicrobial susceptibility was tested and 20% of the microorganisms were considered 
multidrug-resistant. 
 
Table 3. Microbiological analysis 
    Variable n Total n % 
Blood cultures 25 25 100% 
IE with positive blood cultures  20 25 80% 
Streptococcus viridans Group 5 25 20% 
Streptococcus Pneumoniae 1 25 4% 
Streptococcus Grupo D 1 25 4% 
Staphylococcus aureus  6 25 24% 
Staphylococcus epidermidis 1 25 4% 
Staphylococcus Coagulase-negativa 1 25 4% 
Enterococci (including e.faecium and e.fecalis) 3 25 12% 
Salmonella enteritidis 1 25 4% 
    Staphylococci spp. 8 25 32%
Streptococci spp. * 8 25 32% 
Enterococci spp. 3 25 12% 
    Others 1 25 4%
    IE with negative blood cultures 5 25 20%
Previous treatment with antibiotics 3 5 60% 
Serology 3 5 60% 
Negative serology 3 3 100% 
    Serology 7 25 28%
    Antimicrobial susceptibility testing  17 20 85%
MRSA † 2 25 8% 
VRE ‡ 2 25 8% 
Penicilin resistant streptococci 0 25 0% 
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Multidrug-resistant microorganisms 4 25 16% 
    Major Duke criteria - blood cultures positive for IE 13 25 52%
Minor Duke criteria - microbiological evidence 7 25 28% 
    
* in one transferred patient there was register of positive blood cultures for streptococcus spp. but no subgroup 
discrimination. 
†in one of the s.aureus ntimicrobial susceptibility testing was not done 
‡ Vancomycin-resistant enterococci 
 
Echocardiography findings  
 
In all 25 patients either a TTE (68%) or a TEE (88%) was performed within a median time of 
5 days (IQR: 0 – 9 days). Table 4 summarizes echocardiographic findings. A major 
echocardiographic criterion according to the modified Duke criteria of IE (15) was found in 
92% of the patients. These included vegetations in 72% of patients, abscess in 24%, severe 
prosthetic dehiscence in 30% of the patients with prosthetic valves and a new regurgitation in 
72%. Severe regurgitation was commonly found (68%); still, the majority of the cohort had 
normal left-ventricular systolic function (76%). 
Table 4.Echocardiography Findings 
    Variable n Total n % 
TTE 17 25 68% 
TEE 22 25 88% 
Time till TTE/TEE (days) * 5 IQR = 0-9 
 TTE or TEE 25 25 100%
    Vegetations 18 25 72%
Mitral vegetation 4 18 22% 
Aortic vegetation 7 18 39% 
Mitral and aortic  vegetation 4 18 22% 
Tricuspide vegetation 2 18 11% 
Pacemaker lead vegetation 1 18 6% 
    Left-sided IE 15 18 83%
Right-sided IE 2 18 11% 
    Register  of vegetation size 13 25 52%
Vegetation > 10 mm 9 25 36% 
Vegetation >15 mm 5 25 20% 
    Mitral regurgitation 19 25 76%
Mild mitral regurgitation 7 19 37% 
Moderate mitral regurgitation 4 19 21% 
Severe mitral regurgitation 8 19 42% 
Mitral stenosis 1 25 4% 
Aortic regurgitation 14 25 56% 
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Mild aortic regurgitation 1 14 7% 
Moderate aortic regurgitation 2 14 14% 
Severe aortic regurgitation 11 14 79% 
Aortic stenosis 1 25 4% 
Tricuspid regurgitation 12 25 48% 
Mild tricuspid regurgitation 5 12 42% 
Moderate tricuspid regurgitation 5 12 42% 
Severe tricuspidregurgitation 2 12 17% 
Tricuspid stenosis 0 25 0% 
    Regurgitation in more than 1 valve 15 25 60%
Mitral and tricuspid regurgitation 5 25 20% 
Mitral and aortic regurgitation 4 25 16% 
Mitral, aortic and tricuspid regurgitation 6 25 24% 
    Severe regurgitation 17 25 68%
Severe regurgitation in more than 1 valve 4 17 24% 
New regurgitation  18 25 72% 
 
       Paravalvular complications 7 25 28%
Abscess 6 25 24% 
Fistula 4 25 16% 
Pseudoaneurysm 2 25 8% 
Paravalvular leak  2 25 8% 
Severe prosthetic valve dehiscence 3 10 30% 
Mild  to moderate prosthetic valve dehiscence 2 10 20% 
    Qualitative left ventricular systolic function 
   Normal 19 25 76%
Mild to moderate impairment 4 25 16% 
Severe impairment 2 25 8% 
    Major Duke Criteria - Echocardiography  23 25 92%
    * Negative values for time because TTE/TEE has been performed  in the previous hospital (transferred patients) have 
been registered as "0". 
  
Complications  
 
The main complication was congestive heart failure (60%), either if new or an acute 
decompensation of a previous stable condition; approximately half of the patients (56%) had 
AKI. Cerebral embolism was identified in 4 patients (16%) and embolism in other locations 
in 3 patients (12%); 2 of them had an embolic episode in both locations (8%). A total of 7 
patients (28%) developed shock (either septic, cardiogenic or mixed) and 3 patients suffered 
acute pulmonary edema. A total of 18 patients (72%) had at least one clinical complication 
during the stay in hospital. 
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Surgical indications and treatment 
 
The majority of patients (84%) had at least one indication for urgent or emergent surgery as 
presented in Table 5. Approximately half of the patients were submitted to valve replacement 
or repair (48%) after a median 30 days after admission (IQR = 11-40). Table 6 presents all 
surgeries performed. The most common interventions were either aortic replacement (46%) or 
aortic replacement and mitral repair (31%). Out of the 8 patients who had surgical indication 
and did not underwent surgery, 6 died during the index hospitalization (75%).  
Table 5. Indications for surgery and outcomes 
    
Variable n Total n % 
Heart Failure 9 25 36% 
Severe aortic or mitral regurgitation causing APO † or shock 8 25 32% 
Severe aortic or mitral regurgitation and persisting heart failure 6 25 24% 
 
   Uncontrolled infection 8 25 32%
Abscess/False aneurysm/fistula 6 25 24% 
Persisting fever and positive blood cultures for > 10 days 1 25 4% 
Infection caused by multiresistant microorganisms 4 25 16% 
 
   Prevention of embolism 9 25 36%
Vegetations >10mm and predictores of complicated course ϫ 6 25 24% 
Vegetations >15mm 5 25 20% 
 
    
   Urgent and Emergent Surgical indications 21 25 84%
More than one surgical indication 8 21 38% 
 
   Surgical indication not submitted to surgery 8 21 38%
Surgical indication not submitted to surgery who died in-hospital 6 8 75% 
Surgical indication submitted to surgery  13 13 100% 
Surgical indication submitted to surgery who died in-hospital 0 13 0% 
† APO: acute pulmonary oedema    
ϫ Predictors of complicated course: Heart faillure and uncontrolled infection    
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Table 6. Surgical Treatment 
    Variable n Total n % 
Surgery 13 25 52,00% 
Time till Cardiac Surgery (days) IQR(11-40) 30  
Surgery designation    
    Mitral valve repair and aortic replacement 4 12 33% 
Aortic replacement 6 12 50% 
Mitral valve repair 1 12 8% 
Mitral valve replacement 1 12 8% 
Pacemaker leads removal 1 25 4% 
Valve replacement or repair 12 25 48% 
Mechanical prothesis 6 11 55% 
Biological  prothesis 5 11 45% 
 
Outcomes 
 
Mean length of stay in hospital was 42 days (IQR = 27-50). In-hospital all-cause mortality 
rate was 28%. The 6-month mortality rate was 30%; two patients were lost to follow-up, no 
deaths were registered after hospital discharge up to 6 months later. During this period 1 
patient had to be submitted to a new surgery due to immediate surgical complications (1 day 
after the initial surgery) and 1 patient had a re-infection (15 days after initial infection). 
Predictors of in-hospital mortality  
 
In univariate analysis, previous heart valve disease (8,33% vs. 46% p = 0,03), previous 
congestive heart failure (13% vs. 56% p = 0,02) immunosuppression ( 22% vs. 100% p = 
0,018), minor Duke criteria for microbiological evidence (11% vs. 71% p = 0,003), 
multidrug-resistant microorganisms ( 14% vs. 100% p < 0.001) and shock (11% vs. 71% p = 
0,003) were associated with a poorer in-hospital prognosis. Both MRSA and VRE patients 
suffered  a very high  mortality rate compared with other blood culture-positive patients (100% vs 
28% p=0,042). HAIE was associated with a higher in-hospital mortality rate compared with non-HAIE 
(75% vs 20% p=0,027) and community-acquired IE (CAIE)  was associated with  a better prognosis 
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than non-CAIE (16% vs 80% p =0,005). Surgery was associated with decreased in-hospital 
mortality (0% vs. 58% p=0,001). 
As for continuous variables, baseline serum creatinine level (1,16 ± 0,66 vs. 1,82 ± 1,20 
mg/dL p = 0,045), time from hospital admission till cardiology service admission (3 +/- 4 vs . 
13 ± 14 days p = 0.004) and the time till TTE/TEE ( 3 ± 4 vs. 16 ± 8 days p < 0.001) 
influenced in-hospital mortality. Older age was numerically associated with in-hospital 
mortality (57 ± 16 vs. 68 ± 5 years p = 0,06), but did not achieve statistical significance. 
  
Comparison with the 2005-2010 cohort 
 
As part of the analysis conducted in this study, we assessed the temporal trends of IE patients 
admitted in our cardiology department. A cohort of 75 patients admitted from January, 1
st
 
2005 to December, 31
st
 2010 was compared with our contemporary cohort of 25 patients. The 
comparison of IE characteristics in the two study periods are shown in Table 7. 
Of note, the incidence of IE on prosthetic valves has slightly increased (31% to 40%); patient 
risk profile was higher regarding cardiac comorbidities, except for prior cardiothoracic 
surgery, that has remained almost unaltered. The presence of an intracardiac device has 
slightly decreased (27% to 20%). Regarding diagnosis, there was an increase of patients 
submitted either to TTE or TEE (95% to 100%) and more patients were submitted to TEE 
(69% to 88%). 
A causative microorganism was found more frequently in the contemporary cohort (66% to 
80%). The incidence of IE due to Streptococci viridans has doubled (10% to 20%), while it 
has remained stable for Staphylococci spp. and Enterococci spp. More patients were 
submitted to surgical treatment (29% to 52%) and this difference is even more accentuated if 
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only valve replacement or repair is considered (9% to 48%). Both in-hospital (36% to 28%) 
and 6-month (47% to 30%) mortality rates have numerically decreased. 
Table 7. Comparison of 2005-2010  and 2013-2014  cohorts 
 2005-2010 2013-2014 
Variable n Total   n % n Total n % 
Demographic Data       
Age  IQR= 51,5-70,5 62  IQR = 50-75 59 
Male  gender 57 75 76% 19 25 76% 
       Classification       
       Native valve  52 75 69% 0 0 60% 
Prosthetic valve 23 75 31% 10 25 40% 
       Cardiovascular risk factors       
       Arterial hypertension 35 75 47% 16 25 64% 
Dyslipidemia 22 75 29% 12 25 48% 
Diabetes 14 75 19% 8 25 32% 
       Comorbidities       
       Previous degenerative heart valve disease 35 75 47% 13 25 52% 
Coronary disease 5 75 7% 8 25 32% 
Acute myocardial infarction 3 75 4% 4 25 16% 
Previous congestive heart failure 21 74 28% 9 25 36% 
Previous endocarditis 4 74 5% 2 25 20% 
Pacemaker/ICD 20 75 27% 5 25 20% 
Previous cardiothoracic Surgery 35 74 47% 13 25 52% 
Cronic Kidney Failure 9 74 12% 3 25 12% 
Imunosupression  6 74 8% 2 25 8% 
IVDA 4 75 5% 1 25 4% 
       Transthoracic and transesophageal 
echocardiography 
      
       TTE 59 74 80% 17 25 68% 
TEE 51 74 69% 22 25 88% 
TTE or TEE 70 74 95% 25 25 100% 
       Vegetations 55 70 79% 18 25 72% 
Mitral vegetation 19 55 35% 4 18 22% 
Aortic vegetation 29 55 53% 7 18 39% 
Mitral and aortic  vegetation 2 55 4% 4 18 22% 
Tricuspide vegetation 5 55 9% 2 18 11% 
       Left-sided IE 50 55 91% 15 18 83% 
Right-sided IE 5 55 9% 2 18 11% 
       Modified Duke Criteria       
       Major DUKE criteria       
Blood cultures 27 75 36% 13 25 52% 
Echocardiography 63 75 84% 23 25 92% 
Minor  DUKE  criteria       
Predisposing condition 51 74 69% 19 25 76% 
Fever  56 75 75% 20 25 80 % 
Vascular phenomena 13 75 17% 6 25 24% 
Immunological phenomena 4 75 5% 0 25 0% 
Microbiological evidence 12 75 16% 7 25 28% 
       
Microbiology 
       Blood cultures 71 75 95% 25 25 100% 
IE with positive blood cultures 47 71 66% 20 25 80% 
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Positive blood cultures with possible 
contaminations 
7 71 10% 0 25 0% 
Streptococcus viridans Group 7 71 10% 7 25 28% 
Streptococcus Pneumoniae 0 71 0% 1 25 4% 
Streptococcus Grupo D 0 71 0% 1 25 4% 
Streptococcus agalactiae 1 71 1% 0 25 0% 
Staphylococcus aureus 11 71 15% 6 25 24% 
Staphylococcus Coagulase-negativa 2 71 3% 1 25 4% 
Staphylococcus epidermidis e 
staphylococcus hominis 
10 71 14% 1 25 4% 
Enterococcus 5 71 7% 3 25 12% 
Salmonella enteritidis 0 71 0% 1 25 4% 
abiotrophia defectiva (nutrionally variant 
streptococci) 
1 71 1% 0 25 0% 
klebsiella pneumoniae 1 71 1% 0 25 0% 
candida albicans 1 71 1% 0 25 0% 
Serratia marcescens(enterobactereacea) 1 71 1% 0 25 0% 
       Streptococci spp.  9 71 13% 9 25 36% 
Enterococci spp. 5 71 7% 3 25 12% 
Staphylococci spp. 23 71 32% 8 25 32% 
Others 3 71 4% 0 25 0% 
       IE with negative blood cultures 24 71 34% 5 25 20% 
       Antimicrobial susceptibility testing  40 47 85% 17 20 85% 
MRSA 5 75 7% 2 25 8% 
Vancomycin and penicilin resistant 
enterococci 
0 75 0% 2 25 8% 
Penicilin resistant streptococci 2 75 3% 0 25 0% 
Multidrug-resistant microorganisms 7 75 9% 4 25 16% 
       Surgical Treatment       
Surgery 22 75 29% 13 25 52% 
Implantation/substitution/removal of 
pacemaker/ICD leads 
15 75 20% 1 25 4% 
Valve replacement or repair 7 75 9% 12 25 48% 
Time till Cardiac Surgery (days)  IQR(29- 59) 38  IQR(11-40) 30 
       Lenght of stay in hospital (days)  IQR=(17 - 51) 36  IQR=(27-50) 42 
In-hospital  mortality rate 27 75 36% 7 25 28% 
6-month mortality rate 35 75 47% 7 23 30% 
       ϫ Negative values for time because TTE/TEE has been performed  in the previous hospital (transferred patients) have been 
registered as "0". 
 
DISCUSSION 
 
In this prospective observational study on a contemporary IE cohort we registered a decrease 
in both in-hospital (36% to 28%) and 6-month (47% to 30%) mortality rates, in comparison 
with a previous cohort collected during the last decade. Nonetheless, both values are still 
higher than those presented in other contemporary reports (3,5,8,9). 
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Of note, the proportion of patients with prosthetic valves (40%) was especially elevated  (5,8) 
and that might help explain the high mortality rate, giving that PVE is associated with poor 
prognosis (2). A considerable proportion of cases in this study were identified as having 
recent health care exposure (17%), though inferior to contemporary reports (25% - 30%) 
(5,8,10). The percentage  of surgically treated patients, which has substantially increased in 
comparison with the previous series (from 29% to 52%)  was consistent with other recent 
studies (3,5,8). With  concern to causative agents S. aureus IE, which has numerically 
increased compared with the previous cohort (15% to 24%), was slightly less frequent than 
the percentages found in other studies (27% - 32%) (3,5,6,8,10). Anyhow MRSA prevalence 
(33%) was approximately the same found in other series (3,6). 
Our hospital is a tertiary referral center with a cardiac surgery unit and therefore there was a 
high proportion of transferred patients (48%). Nonetheless only two in-hospital deaths were 
registered in this group, allowing us to conclude that referral patients may not contribute to a 
higher intra-hospital mortality, as previously noticed by other studies(5). Anyway, it should 
be mentioned that 85% of all surgeries were performed in referred patients, introducing a 
possible selection bias. 
Regarding the clinical presentation and baseline characteristics of the population, it was also 
registered a significant proportion of patients with cardiovascular risk factors, particularly 
diabetes in 32% of the patients, a value superior to that registered in several other reports (5,8) 
and quite concerning because of its association with poor outcomes of IE (2,18). The presence 
of an intracardiac device (pacemaker or implantable cardioverter-defibrillator) (20%) in this 
cohort was also superior to that registered in the literature (5,8). However, only one patient 
had a pacemaker lead vegetation. An increasing number of predisposing conditions for IE as 
well as other comorbidities was registered, being particularly common the presence of 
degenerative valve disease (52%) following the trend registered in the last decades. 
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Previous heart valve disease (8,33% vs. 46% p = 0,03), previous congestive heart failure 
(13% vs. 56% p = 0,02) and immunosuppression (22% vs. 100% p = 0,018) were associated 
with increased in-hospital mortality concurring with  the existing idea that  patients  with 
baseline comorbidities tend to have worse prognosis (2).  
Despite not being statistically relevant (p = 0,06) patients who died in-hospital had a 
approximately 10 years more (57 ±  16 vs. 68 ± 5) and this reproduces the literature, that 
associates increasing age with poorer prognosis (5,10). 
 Time from hospital admission till cardiology service admission (2,55 ± 4 vs. 13,28 ±  14 days 
p = 0.004) and time till TTE/TEE (3,33 ±  4 vs. 15.85 ± 8 days p<0,001) influenced in-
hospital mortality rate. We might speculate  from this data that patients in which the suspicion 
for IE was raised sooner had a better prognosis, highlighting the importance of IE awareness 
in patients with predisposing conditions. Therefore, patients with fever of unknown origin 
must be closely followed and IE should be one of the working differential diagnosis. 
As mentioned before a relevant proportion of HAIE was registered. This type of IE, which 
appears to be a different entity from non-HAIE (13) has been considered an independent 
predictor of increased mortality (14) and further study of this entity should be 
encouraged. Univariate analysis also supported this difference: HAIE was associated with a 
higher in-hospital mortality rate compared with non-HAIE (75% vs 20% p=0,027) and CAIE 
was associated with  a better prognosis than non-CAIE (16% vs 80% p =0,005).  
With concern to microbiology, it is also worth mentioning that the frequency of  S. viridans 
was similar to other cohorts (5,8), though the proportion of Streptococci spp. was higher than 
in most reports (23% - 29%) (3,5,10). The reason for this is not very clear but it might be due 
to the dimension of the cohort, as it has been referred elsewhere (2) that the shift from 
predominantly streptococcal IE to predominantly staphylococcal IE is not evident in 
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population-based studies. Also, it might be due to the fact that oral health services are not 
contemplated in the national health service plans in Portugal for the general population; poor 
oral hygiene is an established risk factor for IE (19). Moreover, it seems relevant to state  that 
there was a considerable increase on S.viridans IE (10% to 20%) comparing with the previous 
cohort. Though, we suppose that it might be related with the much higher proportion of 
negative blood cultures IE in the older cohort, assuming that in case of previous antibiotic 
therapeutic this agent is among the ones most often untraceable (2).  
In this series Enterococci spp. presented as the third most frequent causative microorganism 
(12%), a value consistent with other reports (5,8). Of note, two out of the three were VRE, 
two of the patients died in-hospital and the third patient was dead at last contact/ follow-up 
(201 days after discharge). There is a paucity of data on Enterococci spp. IE, so further 
understanding of this trend should be promoted. Regarding the two patients with VRE, it 
should be referred that these tend to be very challenging patients with significant underlying 
disease and to whom is very difficult to provide efficient bactericidal antimicrobial therapy 
(20). In univariate analysis multidrug-resistant microorganisms (including MRSA e VRE) 
were associated with poorer prognosis (p = <0.001). 
The only clinical complication associated with increased mortality in univariate analysis was 
shock (11% vs. 71% p = 0,003). Despite the high incidence of AKI (52%) comparing with 
previous studies (8), only baseline serum creatinine (1,16 ± 0,66 vs. 1,82 ± 1,20 mg/dL, p = 
0,045) was associated with  a poorer prognosis. The proportion of patients with at least one 
clinical complication (72%) was similar to literature (3), as were the episodes of congestive 
HF (60%), cerebral embolism (16%) and non-cerebral embolism (12%) (3,5,8).  
With concern to echocardiography findings, the proportion of patients with abscess (24%) and 
severe regurgitation (68%) was higher than in other series. Both these findings are predictors 
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of  poor outcome in patients with IE (2) and might have contributed to the high in-hospital 
mortality rates registered. 
Although the proportion of patients that were surgically treated (52%) was comparable with 
contemporary reports (3,5,8), the median time from diagnosis till surgery was 30 days IQR 
(11-40) days, a value higher than reported in other cohorts (6-10 days) (3,8). Taking in 
account that 84% of the patients had at least one indication for urgent or emergent surgery (2), 
the delay until surgery might have influenced the in-hospital mortality rate, though literature 
is controversial about the impact of surgical timing on outcomes (9,12–14).  
Also, it would be important to better recognize the contra-indications for surgery, considering 
that the group of patients with a guideline-supported indication for surgery who had access 
only to medical treatment was the subgroup with worst prognosis. The in-hospital mortality of 
this group of patients was 75%, upholding to the conclusions of recent reports (3,12). 
However, it would be expected to reach this conclusion giving that normally patients who are 
not submitted to surgery despite indication are also usually those in worst condition. 
Finally, it would be important to mention that considering the comparison between the two 
cohorts, the decrease on mortality rates is probably best explained by an increase in surgically 
treated patients (from 29% to 52%), given that surgery in both cohorts (21), as in other 
reports, is a critical factor associated with reduced mortality (5,9). 
CONCLUSION 
 
In summary, we conclude that IE continues to impose significant in-hospital mortality, 
although a trend to a lower number of deaths was registered during this 10-year period. Gram-
positive agents continue to be the most common pathogens and the initial antibiotic scheme 
must reflect this reality. Surgery is clearly associated with better results and a surgical 
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approach has almost numerically doubled. This may explain the better survival results. IE is 
one of the deadlier cardiovascular diseases and must be approached by a multidisciplinary 
team in a high-dependency environment. 
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